Arbutus to Provide a Corporate Update and Release First Quarter 2016 Financial Results
April 29 2016 - 8:00AM
Arbutus Biopharma Corporation (Nasdaq:ABUS), an industry-leading
Hepatitis B Virus (HBV) therapeutic solutions company, today
announced that it will hold a conference call and webcast on
Wednesday, May 4, 2016 at 1:30 p.m. Pacific Time (4:30 p.m. Eastern
Time) to provide a corporate update and first quarter financial
results.
Conference Call and Webcast
Information
Arbutus will hold a conference call and webcast
on Wednesday, May 4, 2016, at 1:30 p.m. Pacific Time (4:30 p.m.
Eastern Time) to provide a corporate update and report its first
quarter 2016 financial results. A live webcast of the call can be
accessed through the Investor section of Arbutus’ website
at www.arbutusbio.com. Or, alternatively, to access the
conference call, please dial 1-914-495-8556 or 1-866-393-1607.
An archived webcast will be available on the
Arbutus website after the event. Alternatively, you may access a
replay of the conference call by calling 1-404-537-3406 or
1-855-859-2056 and referencing conference ID 2861586.
About Arbutus
Arbutus Biopharma Corporation is a
biopharmaceutical company dedicated to discovering, developing and
commercializing a cure for patients suffering from chronic HBV
infection. Arbutus is headquartered in Vancouver, BC, Canada with
offices in Doylestown, PA, USA. For more information, visit
www.arbutusbio.com.
Contact Information
InvestorsAdam CutlerSenior Vice
President, Corporate AffairsPhone: 604.419.3200 Email:
acutler@arbutusbio.com
Helia Baradarani Manager, Investor Relations Phone:
604.419.3200Email: hbaradarani@arbutusbio.com
MediaPlease direct all media
inquiries to: media@arbutusbio.com
Arbutus Biopharma (NASDAQ:ABUS)
Historical Stock Chart
From Mar 2024 to Apr 2024
Arbutus Biopharma (NASDAQ:ABUS)
Historical Stock Chart
From Apr 2023 to Apr 2024